Octapharma
Plasma-derived medicines for patients with rare diseases, coagulopathies and bleeding disorders
Highlights
- New on EvolcAdded 2026-10-30
About Octapharma
Octapharma develops and supplies medicines sourced from human plasma and human cell lines, including treatments for rare diseases, coagulopathies and bleeding disorders.
The company serves patients and healthcare customers; its UK site provides customer service and product-ordering information. Octapharma Limited is headquartered in Manchester and was founded in 1989. The group reports operations in 31 countries, with medicines reaching 118 countries, and nearly 12,000 employees worldwide.
Product: Medicines sourced from human plasma and human cell lines, including treatments for rare diseases and bleeding disorders.
Jobs at Octapharma
More biotech & pharma companies
Ogi Bio
Automated modular bioreactors and culturing systems for scientists studying microbial growth and culturesNew on EvolcOMass Therapeutics
Drug discovery company developing small-molecule medicines for immunological and orphan diseasesNew on EvolcOppilotech
Computational biology modelling and drug discovery for pharmaceutical and biotech companiesNew on EvolcOptibrium
Drug discovery software for pharmaceutical, biotech and academic teams designing and selecting small-molecule compoundsNew on EvolcOpvia
AI-assisted GxP platform combining LIMS, MES, ELN and QMS for life-science labs and biomanufacturersNew on EvolcOrchard Therapeutics
Develops hematopoietic stem cell gene therapies for severe genetic diseases, with patients, families and clinicians as its audienceRemote-friendly
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Next.js
- React
- Storyblok
- Usercentrics